Aaron Wealth Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $483K | Buy |
31,267
+6,868
| +28% | +$106K | 0.05% | 242 |
|
|
2025
Q1 | $363K | Sell |
24,399
-601
| -2% | -$8.94K | 0.04% | 284 |
|
|
2024
Q4 | $331K | Buy |
25,000
+1,670
| +7% | +$22.1K | 0.04% | 297 |
|
|
2024
Q3 | $332K | Buy |
23,330
+3,162
| +16% | +$45K | 0.04% | 274 |
|
|
2024
Q2 | $261K | Sell |
20,168
-938
| -4% | -$12.1K | 0.04% | 267 |
|
|
2024
Q1 | $293K | Buy |
+21,106
| New | +$293K | 0.04% | 227 |
|
|
2023
Q4 | – | Sell |
-18,403
| Closed | -$285K | – | 286 |
|
|
2023
Q3 | $285K | Buy |
18,403
+5,185
| +39% | +$80.2K | 0.04% | 203 |
|
|
2023
Q2 | $208K | Sell |
13,218
-1,100
| -8% | -$17.3K | 0.03% | 244 |
|
|
2023
Q1 | $236K | Buy |
+14,318
| New | +$236K | 0.03% | 223 |
|
|
2022
Q2 | – | Sell |
-93,581
| Closed | -$6.54M | – | 771 |
|
|
2022
Q1 | $6.54M | Buy |
+93,581
| New | +$6.54M | 0.09% | 109 |
|
|
2021
Q3 | – | Sell |
-58,856
| Closed | -$990K | – | 163 |
|
|
2021
Q2 | $990K | Sell |
58,856
-579
| -1% | -$9.74K | 0.33% | 53 |
|
|
2021
Q1 | $1.09M | Buy |
59,435
+47,296
| +390% | +$863K | 0.4% | 44 |
|
|
2020
Q4 | $220K | Buy |
+12,139
| New | +$220K | 0.08% | 121 |
|